{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T22:00:40Z","timestamp":1775772040369,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T00:00:00Z","timestamp":1715644800000},"content-version":"am","delay-in-days":287,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["101003627"],"award-info":[{"award-number":["101003627"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["101005077"],"award-info":[{"award-number":["101005077"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019771","name":"European Union's Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019771","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.ejmech.2023.115474","type":"journal-article","created":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T21:30:19Z","timestamp":1683754219000},"page":"115474","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Structure-guided optimization of adenosine mimetics as selective and potent inhibitors of coronavirus nsp14 N7-methyltransferases"],"prefix":"10.1016","volume":"256","author":[{"given":"Marcel","family":"Hausdorff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrien","family":"Delpal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1084-6312","authenticated-orcid":false,"given":"Sarah","family":"Barelier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Nicollet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Canard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4734-2249","authenticated-orcid":false,"given":"Franck","family":"Touret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2004-4073","authenticated-orcid":false,"given":"Agathe","family":"Colmant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Coutard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4379-6139","authenticated-orcid":false,"given":"Jean-Jacques","family":"Vasseur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6046-024X","authenticated-orcid":false,"given":"Etienne","family":"Decroly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3422-3926","authenticated-orcid":false,"given":"Fran\u00e7oise","family":"Debart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2023.115474_bib1","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2023.115474_bib2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ijid.2020.10.069","article-title":"Role of favipiravir in the treatment of COVID-19","volume":"102","author":"Joshi","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.ejmech.2023.115474_bib3","first-page":"14","article-title":"Oral antiviral treatment for COVID-19: a Comprehensive review on nirmatrelvir\/ritonavir","author":"Akinosoglou","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2023.115474_bib4","doi-asserted-by":"crossref","first-page":"4518","DOI":"10.1016\/j.bmcl.2016.07.041","article-title":"New small molecule inhibitors of histone methyl transferase DOT1L with a nitrile as a non-traditional replacement for heavy halogen atoms","volume":"26","author":"Spurr","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.115474_bib5","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1007\/s43440-020-00155-6","article-title":"Drug repurposing approach to fight COVID-19","volume":"72","author":"Singh","year":"2020","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejmech.2023.115474_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105252","article-title":"Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern","volume":"198","author":"Vangeel","year":"2022","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2023.115474_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202200440","article-title":"Recent drug development and medicinal chemistry approaches for the treatment of SARS-CoV-2 Infection and COVID-19","volume":"17","author":"Ghosh","year":"2022","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2023.115474_bib8","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.3390\/cells9051267","article-title":"A structural view of SARS-CoV-2 RNA replication machinery: RNA synthesis, proofreading and final capping","volume":"9","author":"Romano","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2023.115474_bib9","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abl4784","article-title":"An oral SARS-CoV-2 M(pro) inhibitor clinical candidate for the treatment of COVID-19","volume":"374","author":"Owen","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2023.115474_bib10","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/nar\/gkab1279","article-title":"Coronaviral RNA-methyltransferases: function, structure and inhibition","volume":"50","author":"Nencka","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2023.115474_bib11","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2108709118","article-title":"Structure-function analysis of the nsp14 N7-guanine methyltransferase reveals an essential role in Betacoronavirus replication","volume":"118","author":"Ogando","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2023.115474_bib12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.coviro.2017.04.003","article-title":"Biochemical principles and inhibitors to interfere with viral capping pathways","volume":"24","author":"Decroly","year":"2017","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.ejmech.2023.115474_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/a0dde376-2eb1-4ce3-8887-d29f5ba6f162","article-title":"In vitro reconstitution of SARS-coronavirus mRNA cap methylation","volume":"6","author":"Bouvet","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2023.115474_bib14","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.antiviral.2017.06.021","article-title":"Toward the identification of viral cap-methyltransferase inhibitors by fluorescence screening assay","volume":"144","author":"Aouadi","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2023.115474_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112557","article-title":"Synthesis of adenine dinucleosides SAM analogs as specific inhibitors of SARS-CoV nsp14 RNA cap guanine-N7-methyltransferase","volume":"201","author":"Ahmed-Belkacem","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115474_bib16","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1042\/BCJ20210219","article-title":"Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp14 RNA cap methyltransferase","volume":"478","author":"Basu","year":"2021","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2023.115474_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ph14121243","article-title":"Discovery of SARS-CoV-2 nsp14 and nsp16 methyltransferase inhibitors by high-throughput virtual screening","volume":"14","author":"Bobrovs","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2023.115474_bib18","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1177\/24725552211026261","article-title":"Probing the SAM binding site of SARS-CoV-2 nsp14 in vitro using SAM competitive inhibitors guides developing selective bisubstrate inhibitors","volume":"26","author":"Devkota","year":"2021","journal-title":"SLAS Discov"},{"key":"10.1016\/j.ejmech.2023.115474_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2021.105142","article-title":"Identification and evaluation of potential SARS-CoV-2 antiviral agents targeting mRNA cap guanine N7-methyltransferase","volume":"193","author":"Kasprzyk","year":"2021","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2023.115474_bib20","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1177\/24725552211000652","article-title":"Development of a high-throughput screening assay to identify inhibitors of the SARS-CoV-2 guanine-N7-methyltransferase using RapidFire mass spectrometry","volume":"26","author":"Pearson","year":"2021","journal-title":"SLAS Discov"},{"key":"10.1016\/j.ejmech.2023.115474_bib21","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1021\/acsmedchemlett.1c00140","article-title":"Potent SARS-CoV-2 mRNA cap methyltransferase inhibitors by bioisosteric replacement of methionine in SAM cosubstrate","volume":"12","author":"Bobileva","year":"2021","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.115474_bib22","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1021\/acsinfecdis.1c00131","article-title":"The structure-based design of SARS-CoV-2 nsp14 methyltransferase ligands yields nanomolar inhibitors","volume":"7","author":"Otava","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2023.115474_bib23","doi-asserted-by":"crossref","first-page":"6231","DOI":"10.1021\/acs.jmedchem.2c00120","article-title":"Potent inhibition of SARS-CoV-2 nsp14 N7-methyltransferase by sulfonamide-based bisubstrate analogues","volume":"65","author":"Ahmed-Belkacem","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115474_bib24","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1021\/acsmedchemlett.2c00265","article-title":"Bisubstrate inhibitors of severe acute respiratory syndrome coronavirus-2 nsp14 methyltransferase","volume":"13","author":"Jung","year":"2022","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.115474_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28020768","article-title":"3-(Adenosylthio)benzoic acid derivatives as SARS-CoV-2 Nsp14 methyltransferase inhibitors","volume":"28","author":"Bobileva","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115474_bib26","doi-asserted-by":"crossref","first-page":"9436","DOI":"10.1073\/pnas.1508686112","article-title":"Structural basis and functional analysis of the SARS coronavirus nsp14-nsp10 complex","volume":"112","author":"Ma","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2023.115474_bib27","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.str.2022.04.014","article-title":"Refolding of lid subdomain of SARS-CoV-2 nsp14 upon nsp10 interaction releases exonuclease activity","volume":"30","author":"Czarna","year":"2022","journal-title":"Structure"},{"key":"10.1016\/j.ejmech.2023.115474_bib28","series-title":"Crystal Structures and Fragment Screening of SARS-CoV-2 NSP14 Reveal Details of Exoribonuclease Activation and mRNA Capping and Provide Starting Points for Antiviral Drug Development","author":"Imprachim","year":"2022"},{"key":"10.1016\/j.ejmech.2023.115474_bib29","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/s41594-022-00828-1","article-title":"High-resolution structures of the SARS-CoV-2 N7-methyltransferase inform therapeutic development","volume":"29","author":"Kottur","year":"2022","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ejmech.2023.115474_bib30","doi-asserted-by":"crossref","first-page":"7582","DOI":"10.1039\/D2OB01569B","article-title":"Facile access to 4'-(N-acylsulfonamide) modified nucleosides and evaluation of their inhibitory activity against SARS-CoV-2 RNA cap N7-guanine-methyltransferase nsp14","volume":"20","author":"Amador","year":"2022","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2023.115474_bib31","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1021\/jm960339p","article-title":"Synthesis, biotransformation, and pharmacokinetic studies of 9-(\u03b2-d-arabinofuranosyl)-6-azidopurine: a prodrug for ara-A designed to utilize the azide reduction pathway","volume":"39","author":"Kotra","year":"1996","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115474_bib32","doi-asserted-by":"crossref","first-page":"16746","DOI":"10.1021\/ja206312b","article-title":"Selective inhibitors of histone methyltransferase DOT1L: design, synthesis, and crystallographic studies","volume":"133","author":"Yao","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2023.115474_bib33","doi-asserted-by":"crossref","first-page":"6248","DOI":"10.1021\/acs.jmedchem.5b00802","article-title":"\u03b1,\u03b2-methylene-ADP (AOPCP) derivatives and analogues: development of potent and selective ecto-5\u2032-nucleotidase (CD73) inhibitors","volume":"58","author":"Bhattarai","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115474_bib34","doi-asserted-by":"crossref","first-page":"9850","DOI":"10.1016\/j.tet.2007.06.107","article-title":"7-Functionalized 7-deazapurine \u03b2-d and \u03b2-l-ribonucleosides related to tubercidin and 7-deazainosine: glycosylation of pyrrolo[2,3-d]pyrimidines with 1-O-acetyl-2,3,5-tri-O-benzoyl-\u03b2-d or \u03b2-l-ribofuranose","volume":"63","author":"Seela","year":"2007","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2023.115474_bib35","doi-asserted-by":"crossref","first-page":"20805","DOI":"10.3390\/molecules201119723","article-title":"A 7-deazaadenosylaziridine cofactor for sequence-specific labeling of DNA by the DNA cytosine-C5 methyltransferase M.HhaI","volume":"20","author":"Kunkel","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115474_bib36","doi-asserted-by":"crossref","first-page":"7422","DOI":"10.1016\/j.bmc.2015.10.040","article-title":"Synthesis and biological profiling of 6- or 7-(het)aryl-7-deazapurine 4\u2032-C-methylribonucleosides","volume":"23","author":"Nau\u0161","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115474_bib37","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1021\/acsinfecdis.0c00829","article-title":"Antiviral activity of 7-substituted 7-deazapurine ribonucleosides, monophosphate prodrugs, and triphoshates against emerging RNA viruses","volume":"7","author":"Milisavljevic","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2023.115474_bib38","doi-asserted-by":"crossref","first-page":"9042","DOI":"10.1016\/j.tet.2005.07.043","article-title":"Synthesis of n-chloroquinolines and n-ethynylquinolines (n=2, 4, 8): homo and heterocoupling reactions","volume":"61","author":"Rodr\u00edguez","year":"2005","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2023.115474_bib39","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1080\/00397911.2012.744841","article-title":"K3PO4-KOH mixture as efficient reagent for the deprotection of 4-aryl-2-methyl-3-butyn-2-ols to terminal acetylenes","volume":"43","author":"Smeyanov","year":"2013","journal-title":"Synth. Commun."},{"key":"10.1016\/j.ejmech.2023.115474_bib40","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1093\/nar\/gkl1119","article-title":"High-yield production of short GpppA- and 7MeGpppA-capped RNAs and HPLC-monitoring of methyltransfer reactions at the guanine-N7 and adenosine-2'O positions","volume":"35","author":"Peyrane","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2023.115474_bib41","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2023.115474_bib42","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.antiviral.2019.05.005","article-title":"Phylogenetically based establishment of a dengue virus panel, representing all available genotypes, as a tool in dengue drug discovery","volume":"168","author":"Touret","year":"2019","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2023.115474_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-70143-6","article-title":"In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication","volume":"10","author":"Touret","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2023.115474_bib44","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/s41586-021-03990-6","article-title":"A pan-serotype dengue virus inhibitor targeting the NS3\u2013NS4B interaction","volume":"598","author":"Kaptein","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2023.115474_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2021.105137","article-title":"Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2","volume":"193","author":"Touret","year":"2021","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2023.115474_bib46","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1093\/emboj\/21.11.2757","article-title":"An RNA cap (nucleoside-2'-O-)-methyltransferase in the flavivirus RNA polymerase NS5: crystal structure and functional characterization","volume":"21","author":"Egloff","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2023.115474_bib47","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02217-16","article-title":"Binding of the methyl donor S-Adenosyl-l-Methionine to Middle East respiratory syndrome coronavirus 2'-O-methyltransferase nsp16 promotes recruitment of the allosteric activator nsp10","volume":"91","author":"Aouadi","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2023.115474_bib48","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera--a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2023.115474_bib49","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2023.115474_bib50","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1021\/ci200227u","article-title":"LigPlot+: multiple ligand-protein interaction diagrams for drug discovery","volume":"51","author":"Laskowski","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2023.115474_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0260958","article-title":"Niclosamide shows strong antiviral activity in a human airway model of SARS-CoV-2 infection and a conserved potency against the Alpha (B.1.1.7), Beta (B.1.351) and Delta variant (B.1.617.2)","volume":"16","author":"Weiss","year":"2021","journal-title":"PLoS One"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423004403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423004403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:56:23Z","timestamp":1759330583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523423004403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":51,"alternative-id":["S0223523423004403"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115474","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-guided optimization of adenosine mimetics as selective and potent inhibitors of coronavirus nsp14 N7-methyltransferases","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115474","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115474"}}